Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PANVAC + BCG vs BCG Alone in NMIBC
NCT02015104Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Dec 2013
- Primary completion
- Sep 2018
- Modality
- Prophylactic Vaccines, DNA Vaccines
- Countries
- 1
01
Overview
A Phase 2 trial of PANVAC in bladder cancer, sponsored by National Cancer Institute. Started Dec 2013; status: completed.
02
Drugs
PANVAC
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT02015104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02015104.